Our Work

We're proud to share Evelyn Cox’s EASD 2022 abstract revealing mental-health disparities among Europeans with diabetes by nationality, gender, and age.

New dQ&A data tracks GLP-1 & SGLT2 trends, patient/HCP insights, satisfaction, and market shifts to guide diabetes drug decisions.

Erik Shoger presented real-world patient insights at the FDA advisory meeting on sotagliflozin, highlighting the need for education and training if approved.